Insights

Strategic Collaborations MedImmune's active partnerships with major pharmaceutical companies like Sanofi Pasteur highlight ongoing opportunities for co-development and licensing agreements, especially in the field of monoclonal antibodies and vaccine technologies.

Innovative Vaccine Portfolio With a history of launching licensed live attenuated influenza vaccines and developing RSV monoclonal antibodies, MedImmune presents a strong pipeline of immunization and infectious disease solutions suitable for expanding market reach.

Research & Development Focus As part of AstraZeneca's global R&D network, MedImmune's focus on biologics and novel pathways across oncology, respiratory, and infectious diseases opens doors for sales opportunities in advanced biotherapeutic products and research services.

Health Sector Expansion Operating in the competitive biotech landscape with revenues between $500 million and one billion, MedImmune's focus on respiratory and infectious diseases positions it well for collaborations with healthcare providers seeking innovative treatment options.

Technology Adoption Utilizing advanced tools like REV dehydration technology and data analytics platforms suggests opportunities to offer tailored solutions and technology partnerships that enhance biopharmaceutical development and manufacturing processes for MedImmune.

MedImmune Tech Stack

MedImmune uses 8 technology products and services including Highcharts, jQuery, Modernizr, and more. Explore MedImmune's tech stack below.

  • Highcharts
    Javascript Graphics
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Moment.js
    Javascript Libraries
  • Frederick
    Marketing Automation
  • DocuSign
    Miscellaneous
  • LinkedIn
    Online Community Software
  • Google Tag Manager
    Tag Management

Media & News

MedImmune's Email Address Formats

MedImmune uses at least 2 format(s):
MedImmune Email FormatsExamplePercentage
LastF@medimmune.comDoeJ@medimmune.com
82%
First.Last@medimmune.comJohn.Doe@medimmune.com
12%
LastFi@medimmune.comDoeJo@medimmune.com
4%
FirstL@medimmune.comJohnD@medimmune.com
2%
First.Last@aviron.comJohn.Doe@aviron.com
50%
FLast@aviron.comJDoe@aviron.com
50%

Frequently Asked Questions

Where is MedImmune's headquarters located?

Minus sign iconPlus sign icon
MedImmune's main headquarters is located at 1 Medimmune Way Gaithersburg, Maryland 20878 United States. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is MedImmune's phone number?

Minus sign iconPlus sign icon
You can contact MedImmune's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MedImmune's stock symbol?

Minus sign iconPlus sign icon
MedImmune is a publicly traded company; the company's stock symbol is MEDI1.

What is MedImmune's official website and social media links?

Minus sign iconPlus sign icon
MedImmune's official website is medimmune.com and has social profiles on LinkedIn.

How much revenue does MedImmune generate?

Minus sign iconPlus sign icon
As of May 2026, MedImmune's annual revenue is estimated to be $1.6B.

What is MedImmune's SIC code NAICS code?

Minus sign iconPlus sign icon
MedImmune's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MedImmune have currently?

Minus sign iconPlus sign icon
As of May 2026, MedImmune has approximately 904 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. B.Chief Executive Officer: M. L.Chief Executive Officer: W. B. B.. Explore MedImmune's employee directory with LeadIQ.

What industry does MedImmune belong to?

Minus sign iconPlus sign icon
MedImmune operates in the Biotechnology Research industry.

What technology does MedImmune use?

Minus sign iconPlus sign icon
MedImmune's tech stack includes HighchartsjQueryModernizrMoment.jsFrederickDocuSignLinkedInGoogle Tag Manager.

What is MedImmune's email format?

Minus sign iconPlus sign icon
MedImmune's email format typically follows the pattern of LastF@medimmune.com. Find more MedImmune email formats with LeadIQ.

When was MedImmune founded?

Minus sign iconPlus sign icon
MedImmune was founded in 1987.

MedImmune

Biotechnology ResearchMaryland, United States501-1000 Employees

MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular, Renal and Metabolic Diseases, and Infection and Vaccines. The MedImmune headquarters is located in Gaithersburg, Md., one of AstraZeneca’s three global R&D centres, with additional sites in Cambridge, UK and South San Francisco, CA. 

For more information, please visit www.medimmune.com

Section iconCompany Overview

Headquarters
1 Medimmune Way Gaithersburg, Maryland 20878 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MEDI1
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1987
Employees
501-1000

Section iconFunding & Financials

  • $500M$1B

    MedImmune's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    MedImmune's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.